Ceregene's Acquisition

Ceregene was acquired by Sangamo Therapeutics on August 26, 2013.

Ceregene is a San Diego-based biotechnology company focused on the development of nervous system growth factors (neurotrophic factors) as treatments for neurodegenerative and retinal disorders using g…

Articles about Ceregene's Acquisition: